📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Agendia

1.1 - Company Overview

Agendia Logo

Agendia

Headquarter: The Netherlands
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of molecular diagnostics and personalized treatment planning for breast cancer, offering MammaPrint (70-gene analysis to assess recurrence risk, results in 6 days or less) and BluePrint (80-gene analysis to determine molecular subtype, results in less than 6 days). Supports research via the FLEX study and trials including SWOG S2206, INSIGHT, and I-SPY2.

Products and services

  • BluePrint: An 80-gene molecular-subtyping test that examines breast tumor profiles to determine molecular subtype and offers insights into tumor behavior and treatment response, with results available in less than 6 days
  • FLEX Study: A large-scale observational study linking full genome profiling with clinical data to explore gene associations in breast cancer through combined genomic and clinical datasets
  • MammaPrint: A 70-gene assay that analyzes tumor biology to assess breast cancer recurrence risk and delivers results in 6 days or less to guide pre- and post-operative treatment decisions

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Agendia

Rewrite Therapeutics Logo

Rewrite Therapeutics

HQ: United States Website
  • Description: Provider of novel DNA writing technologies from a private biotechnology company focused on advancing the field.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Rewrite Therapeutics company profile →
Bluebee Logo

Bluebee

HQ: The Netherlands Website
  • Description: Provider of a secure global, cloud-based accelerated bio-informatics/genomics platform and high-performance genomics solutions to process, analyze, share and store large volumes of genomics data, enabling research and clinical labs to reduce cost and time-to-diagnose.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bluebee company profile →
Spindle Logo

Spindle

HQ: Canada Website
  • Description: Provider of proprietary RNA polymerase technology for large-scale mRNA vaccine production, and platforms that streamline mRNA manufacturing. Offerings include Linea IVT, combining Linea DNA IVT templates with the polymerase to reduce dsRNA impurities, and Linea DNA, an enzymatic, cell-free system for rapid production of high-fidelity DNA for therapeutic applications.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Spindle company profile →
Verve Therapeutics Logo

Verve Therapeutics

HQ: United States Website
  • Description: Provider of clinical-stage genetic medicines for cardiovascular disease, including gene editing therapies VERVE-101 targeting PCSK9 to lower LDL-C in heterozygous familial hypercholesterolemia and ASCVD, and VERVE-201 targeting ANGPTL3 for homozygous and refractory hypercholesterolemia, enabled by a proprietary GalNAc-LNP liver delivery system, with medicines evaluated in clinical trials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Verve Therapeutics company profile →
Tavec Pharma Logo

Tavec Pharma

HQ: Canada Website
  • Description: Provider of injectable cancer therapies using exosome-mediated delivery technology. The company enables delivery by injection of anti-cancer molecules, including regulatory RNA, directly to cancer cells to disrupt growth and metastasis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tavec Pharma company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Agendia

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Agendia

2.2 - Growth funds investing in similar companies to Agendia

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Agendia

4.2 - Public trading comparable groups for Agendia

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Agendia

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Agendia

What does Agendia do?

Agendia is a provider of molecular diagnostics and personalized treatment planning for breast cancer, offering MammaPrint (70-gene analysis to assess recurrence risk, results in 6 days or less) and BluePrint (80-gene analysis to determine molecular subtype, results in less than 6 days). Supports research via the FLEX study and trials including SWOG S2206, INSIGHT, and I-SPY2.

Who are Agendia's competitors?

Agendia's competitors and similar companies include Rewrite Therapeutics, Bluebee, Spindle, Verve Therapeutics, and Tavec Pharma.

Where is Agendia headquartered?

Agendia is headquartered in The Netherlands.

How many employees does Agendia have?

Agendia has 1,000 employees 🔒.

When was Agendia founded?

Agendia was founded in 2010 🔒.

What sector and industry vertical is Agendia in?

Agendia is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Agendia

Who are the top strategic acquirers in Agendia's sector and industry

Top strategic M&A buyers and acquirers in Agendia's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Agendia?

Top strategic M&A buyers groups and sectors for Agendia include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Agendia's sector and industry vertical

Which are the top PE firms investing in Agendia's sector and industry vertical?

Top PE firms investing in Agendia's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Agendia's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Agendia's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Agendia's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Agendia include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Agendia's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Agendia?

The key public trading comparables and valuation benchmarks for Agendia include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Agendia for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Agendia with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Agendia's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Agendia with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Agendia's' sector and industry vertical?

Access recent funding rounds and capital raises in Agendia's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Agendia